Related content

Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs

By Becker Jürgen   Kirsch Axel   Schwarz Frank   Chatzinikolaidou Maria   Rothamel Daniel   Lekovic Vojislav   Jennissen Herbert  

Clinical Oral Investigations, Vol. 10, Iss. 3, 2006-09 ,pp. : 217-224

Springer Publishing Company

Access to resources Recommend Favorite

Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein 2 (rhBMP-2). A pilot study in dogs

By Becker Jürgen   Kirsch Axel   Schwarz Frank   Chatzinikolaidou Maria   Rothamel Daniel   Lekovic Vojislav   Laub Markus   Jennissen Herbert  

Clinical Oral Investigations, Vol. 10, Iss. 3, 2006-09 ,pp. : 225-225

Springer Publishing Company

Access to resources Recommend Favorite

Homeobox protein MSX‐1 inhibits expression of bone morphogenetic protein 2, bone morphogenetic protein 4, and lymphoid enhancer‐binding factor 1 via Wnt/β‐catenin signaling to prevent differentiation of dental mesenchymal cells during the late bell stage

By  

European Journal of Oral Sciences, Vol. 126, Iss. 1, 2018-02 ,pp. : 1-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs₂ osteoblasts on titanium implants

By Schwarz Frank   Rothamel Daniel   Herten Monika   Sculean Anton   Scherbaum Werner   Becker Jürgen  

Clinical Oral Investigations, Vol. 8, Iss. 3, 2004-09 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Immunohistochemical analysis of staged guided bone regeneration and osseointegration of titanium implants using a polyethylene glycol membrane

By Mihatovic Ilja   Golubovic Vladimir   Becker Jürgen   Schwarz Frank  

Clinical Oral Investigations, Vol. 18, Iss. 2, 2014-03 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite